Nicholas A. Haglund

Nicholas A. Haglund

Transplant Surgery

800 East 28th Street
Suite H 2100
Minneapolis, MN 55407

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Development and Independent Validation of a Machine Learning-Based Non-Invasive Venous Waveform Analysis for Heart Failure (NIVAHF) Device to Estimate Pulmonary Capillary Wedge Pressure.

Development and Independent Validation of a Machine Learning-Based Non-Invasive Venous Waveform Analysis for Heart Failure (NIVAHF) Device to Estimate Pulmonary Capillary Wedge Pressure.

Journal: Journal of cardiac failure

Published: May 07, 2026

Baroreflex Function in Cardiovascular Disease.

Baroreflex Function in Cardiovascular Disease.

Journal: Journal of cardiac failure

Published: April 01, 2024

Novel Nebulized Milrinone Formulation for the Treatment of Acute Heart Failure Requiring Inotropic Therapy: A Phase 1 Study.

Novel Nebulized Milrinone Formulation for the Treatment of Acute Heart Failure Requiring Inotropic Therapy: A Phase 1 Study.

Journal: Journal of cardiac failure

Published: March 11, 2023

Impact of Biopsy Proven Liver Fibrosis on Patients Undergoing Evaluation and Treatment for Advanced Heart Failure Surgical Therapies.

Impact of Biopsy Proven Liver Fibrosis on Patients Undergoing Evaluation and Treatment for Advanced Heart Failure Surgical Therapies.

Journal: The American journal of cardiology

Published: November 20, 2022

Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization.

Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization.

Journal: Circulation. Heart failure

Published: December 09, 2021

Thirty-day readmissions among patients with cardiogenic shock who underwent extracorporeal membrane oxygenation support in the United States: Insights from the nationwide readmissions database.

Thirty-day readmissions among patients with cardiogenic shock who underwent extracorporeal membrane oxygenation support in the United States: Insights from the nationwide readmissions database.

Journal: American heart journal plus : cardiology research and practice

Published: October 17, 2021

Impact of ultra-conservative ICD programming in patients with LVADs: Avoiding potentially unnecessary tachy-therapies.

Impact of ultra-conservative ICD programming in patients with LVADs: Avoiding potentially unnecessary tachy-therapies.

Journal: Pacing and clinical electrophysiology : PACE

Published: August 27, 2021

Right Heart Catheterization in Cardiogenic Shock Is Associated With Improved Outcomes: Insights From the Nationwide Readmissions Database.

Right Heart Catheterization in Cardiogenic Shock Is Associated With Improved Outcomes: Insights From the Nationwide Readmissions Database.

Journal: Journal of the American Heart Association

Published: August 23, 2021

Electromagnetic interference from left ventricular assist devices detected in patients with implantable cardioverter-defibrillators.

Electromagnetic interference from left ventricular assist devices detected in patients with implantable cardioverter-defibrillators.

Journal: Journal of cardiovascular electrophysiology

Published: July 07, 2021

Inpatient characteristics, complications, and outcomes of patients with cardiac sarcoidosis: A study from the National Inpatient Sample.

Inpatient characteristics, complications, and outcomes of patients with cardiac sarcoidosis: A study from the National Inpatient Sample.

Journal: Indian heart journal

Published: April 20, 2021

Correction to: The use of enoxaparin as bridge to therapeutic INR after LVAD implantation.

Correction to: The use of enoxaparin as bridge to therapeutic INR after LVAD implantation.

Journal: Journal of cardiothoracic surgery

Published: April 15, 2021

The use of enoxaparin as bridge to therapeutic INR after LVAD implantation.

The use of enoxaparin as bridge to therapeutic INR after LVAD implantation.

Journal: Journal of cardiothoracic surgery

Published: August 19, 2020

Showing 1-12 of 58

Last Updated: 09/26/2026